Cutler Group LLC / CA - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$234,000
+1070.0%
5,500
-62.6%
0.01%
+1000.0%
Q3 2020$20,000
+233.3%
14,700
+335.3%
0.00%
Q4 2019$6,000
-88.2%
3,377
-45.3%
0.00%
-100.0%
Q3 2019$51,000
-12.1%
6,177
-1.6%
0.00%
-20.0%
Q2 2019$58,000
+176.2%
6,277
-81.2%
0.01%
+66.7%
Q1 2019$21,000
+40.0%
33,377
+385.3%
0.00%
+50.0%
Q4 2018$15,000
-40.0%
6,8770.0%0.00%0.0%
Q3 2018$25,000
+8.7%
6,8770.0%0.00%0.0%
Q2 2018$23,000
-50.0%
6,877
-56.4%
0.00%
-33.3%
Q1 2018$46,000
-69.3%
15,777
-61.9%
0.00%
-50.0%
Q4 2017$150,000
-1.3%
41,400
+15.5%
0.01%
+20.0%
Q3 2017$152,000
+52.0%
35,854
-23.1%
0.01%
+66.7%
Q2 2017$100,000
-45.7%
46,648
-13.9%
0.00%
-57.1%
Q1 2017$184,000
-15.6%
54,184
+25.8%
0.01%
-12.5%
Q4 2016$218,000
+3.3%
43,073
+69.7%
0.01%
-11.1%
Q3 2016$211,000
+368.9%
25,378
+121.8%
0.01%
+350.0%
Q2 2016$45,000
-75.1%
11,442
-70.7%
0.00%
-83.3%
Q1 2016$181,000
-61.2%
39,046
-29.1%
0.01%
-53.8%
Q4 2015$467,00055,0460.03%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders